"The fact that the alveolar CO 2 tension is so dependent upon such factors as posture, indicates that alveolar CO 2 is not a physiologic constant, as originally believed by Haldane. Rather, it is a variable: the resultant of all factors affecting the respiratory center. Consequently, we cannot speak of an individual's alveolar CO 2 value unless we specify definitely the conditions under which it was taken." R.J. Main, Am J Physiol 1937; 118,435-40 Reduction in end-tidal PCO 2 in the standing position is not solely due to hyperventilation. The effects of gravity on the circulation contribute to a relative hypocapnia in standing man, via a reduction in cardiac output (less blood flow through the lungs implies less CO 2 delivered to the lungs) and a regional ventilation-perfusion mismatch. Hypocapnia leads to vasoconstriction in the brain. In the following study we use a mathematical model to investigate the relative contribution of a number of respiratory and circulatory transients on end-tidal PCO 2 during posture change.
Introduction
In man the carbon dioxide (CO 2 ) content of the alveolar air is lower in the upright position than in the supine position 85 . In 1937 Main et al. confirmed this observation and explained it as being due to over-ventilation with resulting alkaemia 89 . However, Hitchcock and Ferguson 64 showed the drop in alveolar CO 2 partial pressure (PCO 2 ) upon assuming the erect posture to be independent of alterations in pulmonary ventilation. They attributed the lowered PCO 2 to an increase in functional residual capacity (FRC) in the upright position, and an impairment of CO 2 transport from the dependent parts of the body.
In man assuming the upright position, cardiac output (Q) decreases 116 . Variation in end-tidal partial PCO 2 (PETCO 2 ) reflects variation in Q in the same direction, for example during acute hemodynamic perturbations in anaesthetized patients during constant ventilation 111 . Airway CO 2 levels have been proposed as a monitor of Q during cardiovascular resuscitation 16 . We considered that the postural decrease in Q could well contribute to hypocapnia.
Previous studies have focused on the effect of gravity and body position on the distribution of ventilation 23; 93; 134 , perfusion 3; 127 and ventilation-perfusion (V/Q) ratio 94; 126; 128 in the lung. Gravity induces a perfusion gradient in the upright lung, with a decrease in lung perfusion in apical regions and an increase in perfusion in basal regions. In the standing subject, air expired from alveoli active in gas exchange is diluted by air from apical lung segments which are relatively underperfused, resulting in a decrease in PETCO 2 . In the upright position, FRC and tidal volume (VT) increase, due to lowering of the diaphragm and alveolar expansion due to the lungs' own weight. However, the relative contribution of each of these physiological phenomena to the postural decrease in PETCO 2 is unknown.
With the rising interest in cerebral autoregulation during posture change 14; 29; 43; 56; 67; 96 , which is affected by PCO 2 , we sought to determine the factors leading to transient PETCO 2 variation during standing up from the supine position. We hypothesized that the reduction in Q, and the V/Q mismatch determine the decrease in PETCO 2 upon standing up. To test this hypothesis, we developed a nine-compartment computer model of the lung to simulate breath-to-breath PETCO 2 variations during active standing up. The model includes an FRC, VT and anatomic dead space (VD). Lung perfusion is modelled using stroke volume (SV) and heart rate (HR). Regional V/Q ratios are modelled for each lung compartment, accounting for effects of gravity. Input data to the model are Fick-calibrated breath-to-breath SV of the heart, pulmonary O 2 uptake (VO 2 ), respiratory interval (T RESP ) and VT.
Methods

Model
To assess the underlying physiology determining PETCO 2 transients during posture change, we developed a breath-to-breath model, programmed in MATLAB® (Release 5.2, The MathWorks, Natick, MA). A detailed description of the mathematical model is given in the Appendix. The features of each breath (e.g. arterial and venous CO 2 concentrations) depend on the features of the previous breaths. Input data to the model are (Fick-calibrated) SV determined breath-to-breath, VO 2 and VT. The model is 'paced' by the respiratory interval. Ventilation The model includes nine lung compartments ( Fig. 3 .1, right panel). Each compartment's share of the FRC and VT is determined by its position with the apical compartments smaller than the basal compartments. The distributions of VT and SV, in the supine and the upright position, are approximations based on observations by West 126 (Table 3 .1). The model includes VD. Using an established relation between anatomic VD and height 58 , we set the model VD for men at a greater volume compared to the VD for women (1.4 times), with the VD at 200 ml for men and 140 ml for women in the supine position. In the upright position, these values were increased by 70 ml (see below). The respiratory quotient (RQ), defined as the ratio of carbon dioxide production (VCO 2 ) to VO 2 , normally between 0.7 and 1.0, was set at 0.9.
Circulation The model includes a simplified blood circulation with an arterial compartment (Va), a venous compartment (Vv) and lung capillary gas-exchange compartments (V cap ) (see Fig. 3 .1, left panel). The lung capillary volume and the small venule volume are lumped, as gas exchange occurs in both. The major arteries of the lung are included in the venous compartment; the major veins of the lung are included in the arterial compartment. The total blood volume of 5.6 l is distributed over Vv (4.0 l), Va (1.3 l) and V cap (200 ml) 27 .
Effects of gravity The effects of gravity are modelled as a gravity-induced perfusion gradient in the lung. The distribution of perfusion and ventilation in each lung compartment are based on measurements by West 126 . Distributions of VT, SV, FRC and V cap are summarized in Table 3 .1. In the supine position, SV and VT are distributed equally over all compartments. With nine compartments, in the supine position each lung compartment receives one-ninth of the breath-to-breath SV and VT. In the upright position there is an apical to basal perfusion and ventilation gradient, with increased perfusion and ventilation at the lung base. The perfusion gradient is steeper than the ventilation gradient, resulting in a 7.9 to 0.8 apical to basal V/Q gradient. Furthermore, on going from supine to upright respiratory VD increases 15; 104 . Bjurstedt et al. 15 established an increase in VD in the upright position of +53 ml (anatomical) and +81 ml (physiological). In the model VD increases by 70 ml in the upright position. 
Data set
The physiological data we used to test our model are of eight healthy young subjects (2 women; median age 24 years (21 to 38); median height 183 cm (162 to 191) and median weight 78 kg (50 to 85)) who participated in the study of van Lieshout et al. 124 for which informed consent had been obtained of all participants, which was approved by the ethics committee of Copenhagen (KF 01-120/96) and was performed according to the declaration of Helsinki. Instrumentation occurred as described previously; after five minutes of supine rest, each subject actively assumed the upright position and remained standing for five minutes while continuous finger arterial blood pressure (ABP) and breath-to-breath online gas concentrations were recorded. The data we analysed were from a recording of each subject standing up just once. For the purpose of tracking short-term PETCO 2 variations with posture change, we selected data starting 150 second prior to standing up and ending after 150 seconds of standing up.
Mean arterial blood pressure was measured with a Finapres (Model 5; Netherlands Organization for Applied Scientific Research, Biomedical Instrumentation, TNO-BMI).
The cuff was applied to the midphalanx of the middle finger of the dominant arm, which was placed at heart level. Beat-to-beat changes in SV were estimated by modelling flow from arterial pressure (Modelflow®, TNO-BMI). This method computes an aortic waveform from a peripheral arterial pressure signal using a non-linear 3-element model of the aortic impedance 57; 71 . Cardiac output was the product of SV and HR. To obtain absolute values of Q to calibrate Modelflow® Q, a Fick-determined Q was obtained from arterial and central venous O 2 content and the VO 2 in the supine and in the standing position. Absolute values of Q were used to calibrate Modelflow® Q, averaged during 150 seconds in the supine position, and during 150 seconds of standing.
Breath-to-breath online gas analysis was performed using a Med-Graphics CPX/D metabolic cart. Respiratory gas was sampled continuously from a mouthpiece and partial gas pressures were obtained from a Zirkonia oxygen analyzer (accuracy ± 0.03% O 2 ) and a nondispersive infrared sensor for CO 2 (accuracy ± 0.05% CO 2 ) that thus delivered VO 2 , VCO 2 and PETCO 2 .
Data processing and analysis The ventilatory gas analysis was recorded as one value for every breath. All data were stored on a hard disk for off-line analysis. Mean ABP, HR and the ventilatory data were expressed in absolute values. Mean ABP was the integral of one beat. Heart rate was the inverse of the inter-beat interval. Then, ventilatory data and Fick-calibrated Modelflow® SV data were time aligned. For the duration of each breath, the sum of stroke volumes was taken to obtain breath-to-breath SV data.
Experiments
To verify the contribution of the postural reduction in Q to hypocapnia in the standing position, the following protocol was carried out in seven healthy nonsmoking subjects aged 29±5 years, height 176±8 cm, and weight 71±11 kg. Informed consent was obtained in all participants. The study was approved by the ethics committee of the Academic Medical Center (MEC 01-147) and performed according to the declaration of Helsinki. First, the effect of increased ventilation was eliminated by using a protocol that involved standing up during controlled breathing. Second, we eliminated the effect of V/Q mismatch, FRC increase and increased ventilation. To achieve this we used a protocol involving standing with inflated leg splints (Pneumasplint, International deposit Nr. 844181), which augment venous return, followed by rapid leg splint deflation, with breathing frequency and VT controlled. The subjects breathed through a mouthpiece connected to a two-way respiratory valve, and were instructed to breathe at a metronomepaced frequency (0.15 Hz). For each subject the airflow was adjusted to a comfortable level (8.2±1 l/min). During expiration the inflow of air filled a bag, and during inspiration the subject was instructed to empty the bag, thus maintaining a constant VT. Keeping the breathing fixed, 5 minutes of supine recording were followed by 5 minutes of recording in the standing position. Next, while in the standing position inflatable hip-to-toe leg splints were inflated to 60 mmHg. After 5 minutes recording during standing with inflated splints, the splints were deflated to atmospheric pressure within 4 seconds, followed by 5 minutes recording in standing position with deflated splints. The respiratory frequency and VT were fixed throughout the procedures. We measured finger ABP (Finometer Model 1, TNO-BMI) and PCO 2 (Hewlett Packard Airway Adapter 1436A). SV was derived from the peripheral arterial pressure signal using Modelflow® as described above. Measurements of Q were carried out at the beginning and at the end of each procedure using the inert gas rebreathing technique (Innocor Model: SpO 2 & O 2 options 48 ). Rebreathing episodes were marked and Modelflow® Q was level-corrected. The sum of FRC and VD was measured in the supine and standing position also using Innocor rebreathing technique. Calculation is based on the dilution of insoluble gas (SF 6 ). Measurement of FRC and VD combined, in both supine and standing positions, allowed us to analyse the effect of FRC increase as measured, on the PETCO 2 .
Parameter sensitivity analysis
To assess the relative contribution of the various physiological phenomena contributing to PETCO 2 variations, the parameter sensitivity of the model was analysed. First, the effect of variations in VT, VD, SV, VO 2 , RQ, FRC, Vv, Va, T RESP and V/Q on model output (M-PETCO 2 ) were evaluated by carrying out a series of simulations in which a steady-state period of 200 s was followed by a 900 s period with one input parameter set at a value ranging from -10% to +10% of baseline value. An exception is the V/Q parameter sensitivity, which was determined starting with 200 s steady-state 'supine' settings, followed by 900 s with 'upright' settings. Steady-state values were: VT = 484 ml; VD = 200 ml; SV = 550 ml; VO 2 = 250 ml min -1 ; RQ = 0.9; FRC = 2.5 l; Vv = 4.0 l; Va = 1.3 l; T RESP = 4 s and V/Q = 'supine'. The output value used in the analysis was M-PETCO 2 at maximum value or at end-point. Second, the analysis was also performed with the input starting at baseline and varying each input variable as occurs during posture change with an increase in VT, VD and FRC, a reduction in SV, and a shift in V/Q.
Statistical analysis
Hemodynamic and respiratory variables were tested for normality (Shapiro-Wilk test) and, where distribution was not normal, the median was computed for each body position. Results were expressed as mean and standard deviation (SD) or as median and range, as appropriate. Supine and upright values were compared by paired t-test. Agreement between PETCO 2 and M-PETCO 2 was judged by plotting the difference between M-PETCO 2 and PETCO 2 against their mean, and computing Pearson's correlation coefficient. The mean difference (bias) and SD (precision) between M-PETCO 2 and PETCO 2 was tested by paired t-test. A P-value < 0.05 was considered to indicate a statistically significant difference.
Results
Input to the model
The group average hemodynamic and ventilatory responses to standing up from the test database are given in Table 3 .2. Upon standing, Q decreased from 6.5±1.1 l min -1 to 4.0±0.9 l min -1 in the standing position. The Q response ranged from -0.6 l min -1 to -4.5 l min -1 . VT increased on standing up, while the respiratory rate decreased. VE increased on standing up in all subjects, with a range of 0.3 l min -1 to 5.9 l min -1
. The PETCO 2 decreased from 40±1 to 36±2 mmHg. 3A shows the pooled results of breath-to-breath M-PETCO 2 , plotted against the pooled PETCO 2 measurements. There was a significant correlation between M-PETCO 2 and PETCO 2 (r 2 = 0.74, P <0.05). The difference between PETCO 2 and M-PETCO 2 , versus the average PETCO 2 is shown in Figure 3 .3B. Accuracy (group-averaged M-PETCO 2 -PETCO 2 difference) and precision (SD of the M-PETCO 2 -PETCO 2 difference) of the model during the simulation were -0.16 and 1.93 mmHg respectively (95% limits of agreement were -3.95 and +3.63 mmHg).
Model simulation
Experiments
To verify the contribution of the postural reduction in Q to hypocapnia in the standing position, a protocol of standing up during controlled breathing, and the deflation of leg splints was applied on seven subjects. Throughout standing up and deflation of leg splints, the minute ventilation was fixed (the level ranged from 7 to 9.5 l/min) and breathing frequency was maintained at 0.15 Hz.
Supine vs. standing On average the sum of FRC and VD increased from 2.8±0.8 l in the supine position to 3.3±0.3 l in the upright position (p=0.22). The group average mean ABP was 84±8 mmHg supine vs. 87±13 mmHg standing (n.s.), whereas HR increased from 74±5 to 89±7 bpm (P<0.001). With VT and T RESP fixed, both Q (-0.6 to -3.1 l/min) and PETCO 2 (-2.3 to -3.5 mmHg) decreased on going from supine to standing, (Fig.  3.4) . In other words, PETCO 2 decreased in the upright position even though the depth and rate of breathing were kept constant. However, the decrease in PETCO 2 and the decrease in Q showed a correlation coefficient (r 2 ) of only 0.06.
Inflated vs. deflated leg splints
The group average mean ABP was 88±11 mmHg with inflated splints vs. 86±10 mmHg with deflated splints (n.s.), whereas HR increased from 80±8 to 93±10 bpm (P=0.02). Following deflation of splints, Q decreased (-0.1 to -1.1 l/min) and PETCO 2 decreased (ranging from -1.4 to -3.6 mmHg) in all subjects, while VT and T RESP were fixed (Fig. 3.4) . The correlation between the decrease in Q and PETCO 2 yielded a correlation coefficient of r 2 =0.80. 
Parameter sensitivity analysis
The sensitivity of the model output to variations in parameters and model input was analysed. This resulted in a transient change in model output, a progressive variation or no variation in the output.
Transient M-PETCO 2 change A decrease in SV resulted in a transient reduction in PETCO 2 with a peak after six breaths (Fig. 3.5A) . The model response to SV change was asymmetrical: a decrease in SV had a greater effect on PETCO 2 than an increase in SV of similar magnitude. The model response to an increase in FRC was transient, the peak response occurred at the first breath and rapidly decayed (Fig. 3 .5B). The model response to FRC variation also showed asymmetry; an decrease in FRC yielded a greater M-PETCO 2 variation than an increase in FRC of the same magnitude.
Progressive M-PETCO 2 change A strong influence on model output was exerted by changes in VT, T RESP , VO 2 , RQ and VD (Fig. 3.6 ). The effects of T RESP , VO 2 and RQ on M-PETCO 2 were equal, as can be expected from Eq. 4 (see Appendix), where the VCO 2 per breath is determined by VO 2,n , the RQ and the breath duration. The V/Q gradient was analysed by comparing a model run with homogeneous perfusion distribution (as in the supine position) to a model run with a gravity-induced lung-perfusion gradient (as in the standing position). The steady-state model run with 'supine' V/Q distribution resulted in a baseline PETCO 2 of 40 mmHg. After the model run with 'upright' V/Q distribution, the PETCO 2 was 38.4 mmHg after 900 s.
No M-PETCO 2 change A 10% increase or decrease in Vv or Va did not influence model outcome of PETCO 2 . However, an increase in Va or Vv results in increased damping of breathing pattern-related variation in PETCO 2 .
Posture induced variations
The contribution of each parameter on PETCO 2 as is likely to occur during posture change is given in Figure 3 .7. For example, a 20% increase in VT resulted in a progressive decrease in PETCO 2 which dropped from 40 to 34 mmHg after a 300 s model run. An increase in FRC resulted in acute hypocapnia which lasted for several breaths. After 300 s however, the PETCO 2 was only 1 mmHg below supine levels. The posture-dependent change in the V/Q mismatch per se had a limited effect on the decrease in PETCO 2 .
Computed effect of FRC and VD increase upon standing
We conducted an additional analysis of the increase in FRC and VD, which occur simultaneously during tilt. On average the sum of FRC and VD increased from 2.8±0.8 l in the supine position to 3.3±0.3 l in the upright position (p=0.22). We used model (male) supine steady state settings (see above) to analyse the effect on PETCO 2 , where an FRC of 2.5 l and VD at 0.2 l results in a PETCO 2 of 40 mmHg. By increasing FRC to 2.93 l and VD increased to 0.27 (VD is known to increase by ≈70 ml in the upright position; together VD and FRC now amount to 3.2 l), computed PETCO 2 transiently decreased by 12% in the first breath. However, after 9 breaths the hypocapnia had completely disappeared, and after 13 breaths PETCO 2 had increased to above steady state levels. Therefore, an increase in FRC and VD combined induce hypocapnia only in the first 40 seconds.
Discussion
The present study determined the relative contributions of increased ventilation and FRC, slight V/Q mismatch, and decreased cardiac output to the postural decrease in PETCO 2 . For this we developed a mathematical model based on respiratory and circulatory physiology, which predicted PETCO 2 variations during the transition from supine to standing and for 2.5 minutes in the upright position. The model is sensitive to changes in VT, FRC and VD, SV, T RESP , VO 2 , RQ, and V/Q , all of which affect model output, i.e., PETCO 2 (Figs. 3.5, 3.6 and 7). Stroke volume transiently affects model PETCO 2 with a maximal effect after several breaths (Fig. 3.5A ). This response is asymmetrical, with a greater effect from a decrease in SV compared to an increase in SV. An increase in FRC causes a transient decrease in model PETCO 2 (Fig. 3 .5B). However, with the concomitant increase in VD, the FRC-induced hypocapnia is of limited duration (≈40 s). A gravitation-induced slight V/Q mismatch as occurs during standing up (Fig. 3.1, Table 3 .1) contributes to the decrease in PETCO 2 . RQ affects model PETCO 2 levels, but does not vary on a breath-to-breath basis. Thus, the VT increase and SV reduction when standing up are the physiological events primarily responsible for the decrease in PETCO 2 , whereas a gravity-induced V/Q mismatch and transiently, an increase in FRC contribute to hypocapnia. Each line represents a model run where after 200 breaths under baseline conditions the input is changed from its baseline value by -10% to +10%, in steps of 2%. In A the input is SV of the heart, in B the input is FRC. Note difference in ordinate scale.
The predominant influence of Q on hypocapnia in the standing position was verified in experiments on human subjects, using a protocol in which first breathing alone and then breathing, FRC and V/Q were controlled. The correlation between the decrease in Q and in PETCO 2 (r 2 =0.80), in the absence of alternations in breathing, FRC and V/Q indicates that the postural decrease in Q contributes to hypocapnia. Parameter sensitivity analysis of model input (T RESP , VT, VO 2 ) and model parameters (VD and RQ). Model input is changed from baseline by -10% to +10% (see Methods) and model output (PETCO 2 ) determined after 900 s.
Limitations
The lung model presented is, by design, a simplified representation of lung ventilation and perfusion, and has limitations. First, the model circulation is simplified into a venous, an arterial and a lung capillary compartment. There is no bronchial arterial shunt included, because its effect on the PETCO 2 is thought to be small and not likely to vary with posture change. Autoregulation of the lung is not included in our model, and the model circulation does not include a venous pooling reservoir, although venous pooling has profound effects on PETCO 2 64 . We considered a pooled venous reservoir with high PCO 2 levels in blood and interstitium likely to affect the PETCO 2 when assuming the supine position after prolonged standing rather than on going from a supine position to standing up. When pooled blood with elevated PCO 2 returns to the heart and subsequently reaches the lungs, this will result in a PETCO 2 'overshoot'. Interstitial space, and CO 2 transfer to and from extracellular space are not modelled, nor are changes in haemoglobin concentration due to haemoconcentration during standing. The model was designed for short-term PETCO 2 variability and we assumed that changes in haemoglobin concentration are minor.
The apex to base V/Q distribution inequality in the standing position results in a decrease in PETCO 2 because the air expired from alveoli active in gas exchange is diluted by air from apical lung segments which are relatively underperfused, suggesting that the reduction in PETCO 2 will be more pronounced than the reduction in arterial PCO 2 when standing up. In 1962 Bjurstedt et al. 15 observed that changing from the supine to the standing position was associated with a significant rise in the arterial to end-tidal PCO 2 difference. However, our current model and experimental data do not allow us to analyse the arterial to end-tidal PCO 2 difference due to the afore mentioned model limitations, including the absence of a bronchial arterial shunt, a venous pooling reservoir and lungautoregulation. To convert [CO 2 ] to PCO 2 and vice versa, we fitted blood CO 2 equilibrium curves (see Appendix), without accounting for O 2 -dependency. We did not implement Kelman's digital computer procedure for conversion of PCO 2 into blood CO 2 content, which in our model would yield a linear relationship because haemoglobin concentration and temperature are assumed to remain constant ( 76 ).
Step changes in Vv and in Va did not influence PETCO 2 in the sensitivity analysis, where all other model settings were kept constant. This does not imply that settings for Vv and Va are of no consequence. These compartments act as buffers for PETCO 2 changes brought about by variations in VT, SV, etc. Therefore, a larger Vv or Va will result in damping of PETCO 2 variations.
Several model parameters are estimated based on previous studies. The distribution of ventilation and perfusion in the upright position are based on measurements of West 126 . The distribution of ventilation and perfusion over the lung are influenced by a gravity-invoked hydrostatic pressure gradient (perfusion) and a pleural pressure gradient influencing the alveolar pressure/volume relationship (ventilation). Although in the supine position there is still some effect of gravity, this will be less because the vertical height of the lung is less than in the upright position. Therefore, we chose to model the distribution of ventilation and perfusion in the supine position as equally distributed from apex to base.
Conclusions
In human subjects assuming the upright position, end-tidal CO 2 levels drop. The present study shows that the CO 2 levels during posture change can be tracked using a mathematical model, with breath-to-breath values for tidal volume, stroke volume, pulmonary O 2 uptake and respiratory interval as input variables. We found that the decrease in end-tidal CO 2 level in the standing position is due to increased tidal volume and, transiently, decreased cardiac output increased FRC, and that the gravity-induced slight ventilation/perfusion mismatch contributes to the hypocapnia. 
Model equations
Conversion and weight functions The CO 2 equilibrium curve relating blood CO 2 content ([CO 2 ]) to blood partial CO 2 pressure (PCO 2 ) is described as [CO 2 To convert PCO 2 in air (mmHg) to [CO 2 ] (%), we use the conversion factor c, which amounts to 0.1316 %/mmHg. The distribution of SV and VT over each lung compartment k (k = 1…9) is described by functions g and h, respectively. These functions, which are different for the supine and upright positions and yield the fractions for SV and VT listed in Table 3 . Each lung compartment's share of FRC, V cap and VD is given by the weight function w(k) = 0.10055 · (1.36708 -exp(-0.3393k) ) which yields the fractions for FRC and V cap listed in Table 3 .2.
Venous CO 2 For each breath n, the venous CO 2 content ([CO 2 ] v, n ) is calculated from its previous value [CO 2 ] v, n-1 according to Eqs. 1-4. The amount of CO 2 in the venous compartment increases by the amount that arrives from the arterial compartment (A) and the amount created by the basal metabolism (B), and decreases by the amount that leaves the compartment (C). Thus, we have where VO 2, n is the oxygen extraction for breath n (in ml min -1 ) and RQ is the respiratory quotient, which is set at 0.9 (the average as approximated from subject data, by dividing VCO 2 by VO 2 ). The term is multiplied by the breath duration in min (T RESP,n / 60) to estimate the CO 2 produced per breath.
Arterial CO 2 The arterial blood CO 2 content for breath n ([CO 2 ] a, n ) is calculated from its previous value [CO 2 ] a, n-1 according to Eqs. 5 -7. The amount of CO 2 in the arterial compartment increases by the amount of CO 2 arriving from the lungs (D) and decreases by the amount of CO 2 leaving the arterial compartment (E): Where f is the above function that relates blood CO 2 content to the blood partial CO 2 pressure and g is the above function that defines the distribution of SV over the nine lung compartments. The amount E is given by (Eq. 7) E = [CO 2 ] a, n-1 · SV n
